Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati… - Bmj, 2015 - bmj.com
Protocols of systematic reviews and meta-analyses allow for planning and documentation of
review methods, act as a guard against arbitrary decision making during review conduct …

Industry sponsorship and research outcome

A Lundh, J Lexchin, B Mintzes… - … of systematic reviews, 2017 - cochranelibrary.com
Background Clinical research affecting how doctors practice medicine is increasingly
sponsored by companies that make drugs and medical devices. Previous systematic …

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman… - Bmj, 2013 - bmj.com
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …

Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study

MJ Page, L Shamseer, DG Altman, J Tetzlaff… - PLoS …, 2016 - journals.plos.org
Background Systematic reviews (SRs) can help decision makers interpret the deluge of
published biomedical literature. However, a SR may be of limited use if the methods used to …

Increasing value and reducing waste: addressing inaccessible research

AW Chan, F Song, A Vickers, T Jefferson, K Dickersin… - The Lancet, 2014 - thelancet.com
The methods and results of health research are documented in study protocols, full study
reports (detailing all analyses), journal reports, and participant-level datasets. However …

[HTML][HTML] Dealing with the positive publication bias: Why you should really publish your negative results

A Mlinarić, M Horvat, V Šupak Smolčić - Biochemia medica, 2017 - hrcak.srce.hr
Sažetak Studies with positive results are greatly more represented in literature than studies
with negative results, producing so-called publication bias. This review aims to discuss …

Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A review

MJ Page, JAC Sterne, JPT Higgins… - Research synthesis …, 2021 - Wiley Online Library
AP value, or the magnitude or direction of results can influence decisions about whether,
when, and how research findings are disseminated. Regardless of whether an entire study …

Failure of investigational drugs in late-stage clinical development and publication of trial results

TJ Hwang, D Carpenter, JC Lauffenburger… - JAMA internal …, 2016 - jamanetwork.com
Importance Many investigational drugs fail in late-stage clinical development. A better
understanding of why investigational drugs fail can inform clinical practice, regulatory …

Why clinical trial outcomes fail to translate into benefits for patients

C Heneghan, B Goldacre, KR Mahtani - Trials, 2017 - Springer
Clinical research should ultimately improve patient care. For this to be possible, trials must
evaluate outcomes that genuinely reflect real-world settings and concerns. However, many …

COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time

B Goldacre, H Drysdale, A Dale, I Milosevic, E Slade… - Trials, 2019 - Springer
Background Discrepancies between pre-specified and reported outcomes are an important
source of bias in trials. Despite legislation, guidelines and public commitments on correct …